Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Debridement & negative-pressure wound therapy · Michigan | Debridement & negative-pressure wound therapy · Illinois | |
|---|---|---|
| Surgeons, 2024 | 430 | 639 |
| Medicare fee-for-service cases | 65,322 | 135,945 |
| Growth since 2019 (Medicare FFS) | −6%/yr | −2.4%/yr |
| Forecast cases (Medicare FFS) | 65,100 in 2030 | 136,300 in 2030 |
| Forecast growth | 0%/yr to 2030 | 0%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 73.0 | 94.5 |
| Medicare Advantage share | 66% | 47% |
| Out of hospital | 40% (−6 pts since 2019) | 44% (−5 pts since 2019) |
| Cases per surgeon | 152 | 213 |
| Top 10 surgeons' share | 15% | 12% |
| Surgeons growing | 83 | 135 |
| New since the base year | 129 | 222 |
| Likely to stop billing it | 62 by 2026 | 72 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $938 | $1,135 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.